| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Neurology and Pediatrics, University of Utah School of Medicine, Salt Lake City, UT.
To characterize the antibody response to the Epstein-Barr virus (EBV) in MS, we studied serum anti-EBV nuclear antigen (anti-EBNA) and anti-EBV capsid antigen (anti-EBVC A) titers. Both titers were assayed in 93 age- and sex-matched pairs of MS patients and controls. Anti-EBVCA titers were measured by indirect immunofluorescence and anti-EBNA titers by anticomplement immunofluorescence. The seropositivity rate of both anti-EBVCA and anti-EBNA in MS patients was l00%, compared with 84% in controls (p < 0.0001). Both anti-EBVCA and anti-EBNA titers were significantly higher in MS patients than in controls (p < 0.0001). The data suggest that EBV has a significant seroepidemiologic association with MS, but they do not define what role EBV antibodies play in the pathogenesis of the disease.
Address correspondence and reprint requests to Dr. Larsen, Department of Pediatrics, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284.
Supported in part by the Public Health Services Research Grant NRR-64 from the Division of Research Resources (Clinical Research Center), The Clipped Wings Foundation® (United Airlines Stewardess Alumnae). and the local Multiple Sclerosis Society.
An abstract of this material was presented at the annual meeting of the American Neurological Association, New Orleans, October 1983.
Accepted for publication June 22, 1984.
This article has been cited by other articles:
|
|
 |
|
  M P Pender, P A Csurhes, A Lenarczyk, C M M Pfluger, and S R Burrows Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, May 1, 2009; 80(5): 498 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nielsen, K Rostgaard, J Askling, R Steffensen, A Oturai, C Jersild, N Koch-Henriksen, P. Sorensen, and H Hjalgrim Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis Multiple Sclerosis, April 1, 2009; 15(4): 431 - 436. [Abstract] [PDF]
|
|
|
|
 |
|
 L. I. Levin, K. L. Munger, M. V. Rubertone, C. A. Peck, E. T. Lennette, D. Spiegelman, and A. Ascherio Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis JAMA, May 25, 2005; 293(20): 2496 - 2500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Alotaibi, J. Kennedy, R. Tellier, D. Stephens, and B. Banwell Epstein-Barr Virus in Pediatric Multiple Sclerosis JAMA, April 21, 2004; 291(15): 1875 - 1879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. I. Levin, K. L. Munger, M. V. Rubertone, C. A. Peck, E. T. Lennette, D. Spiegelman, and A. Ascherio Multiple Sclerosis and Epstein-Barr Virus JAMA, March 26, 2003; 289(12): 1533 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ascherio, K. L. Munger, E. T. Lennette, D. Spiegelman, M. A. Hernan, M. J. Olek, S. E. Hankinson, and D. J. Hunter Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study JAMA, December 26, 2001; 286(24): 3083 - 3088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Caruso, G. A. Tung, G. G. Gascon, J. Rogg, L. Davis, and W. D. Brown Persistent Preceding Focal Neurologic Deficits in Children With Chronic Epstein-Barr Virus Encephalitis J Child Neurol, December 1, 2000; 15(12): 791 - 796. [Abstract] [PDF]
|
|
|
|
 |
|
 K.-P. Wandinger, W. Jabs, A. Siekhaus, S. Bubel, P. Trillenberg, H.-J. Wagner, K. Wessel, H. Kirchner, and H. Hennig Association between clinical disease activity and Epstein-Barr virus reactivation in MS Neurology, July 25, 2000; 55(2): 178 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. van Sechel, M. J. B. van Stipdonk, C. Persoon-Deen, S. B. Geutskens, and J. M. van Noort EBV-Induced Expression and HLA-DR-Restricted Presentation by Human B Cells of {alpha}B-Crystallin, a Candidate Autoantigen in Multiple Sclerosis J. Immunol., January 1, 1999; 162(1): 129 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H Rand, H. Houck, N. D Denslow, and K. M Heilman Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 48 - 55. [Abstract] [Full Text]
|
|
|
|
|
|
K.-M. Myhr, T. Riise, E. Barrett-Connor, H. Myrmel, C. Vedeler, M. Gronning, M. B. Kalvenes, and H. Nyland Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway J. Neurol. Neurosurg. Psychiatry, April 1, 1998; 64(4): 539 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Haahr, N Koch-Henriksen, A Moller-Larsen, L. Eriksen, and H. Andersen Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study Multiple Sclerosis, June 1, 1995; 1(2): 73 - 77. [Abstract] [PDF]
|
|
|
|
|
|
M Munch, A Moller-Larsen, T Christensen, N Morling, H J Hansen, and S Haahr B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus Multiple Sclerosis, June 1, 1995; 1(2): 78 - 81. [Abstract] [PDF]
|
|
|
|
 |
|
 P. V. Shirodaria, M. Haire, E. Fleming, J. D. Merrett, S. A. Hawkins, and S. D. Roberts Viral Antibody Titers: Comparison in Patients With Multiple Sclerosis and Rheumatoid Arthritis Arch Neurol, December 1, 1987; 44(12): 1237 - 1241. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
